⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for refractory differentiated thyroid gland carcinoma

Every month we try and update this database with for refractory differentiated thyroid gland carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid CancerNCT03914300
Differentiated ...
Follicular Vari...
Poorly Differen...
Refractory Diff...
Refractory Thyr...
Tall Cell Varia...
Thyroid Gland F...
Thyroid Gland O...
Thyroid Gland P...
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Ipilimumab
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVNCT04514484
Advanced Differ...
Advanced Head a...
Advanced Hepato...
Advanced Kaposi...
Advanced Lung N...
Advanced Lung S...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Advanced Prosta...
Advanced Renal ...
Advanced Thyroi...
Advanced Triple...
Advanced Urothe...
Anatomic Stage ...
Anatomic Stage ...
Castration-Resi...
Clinical Stage ...
Clinical Stage ...
HIV Infection
Metastatic Diff...
Metastatic Head...
Metastatic Hepa...
Metastatic Kapo...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Ovar...
Metastatic Pros...
Metastatic Rena...
Metastatic Thyr...
Metastatic Trip...
Metastatic Urot...
Recurrent Diffe...
Recurrent Head ...
Recurrent Hepat...
Recurrent Kapos...
Recurrent Lung ...
Recurrent Lung ...
Recurrent Malig...
Recurrent Melan...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Thyro...
Recurrent Tripl...
Recurrent Uroth...
Refractory Diff...
Stage III Diffe...
Stage III Hepat...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Thyro...
Stage IV Differ...
Stage IV Hepato...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Thyroi...
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid CancerNCT01208051
Refractory Diff...
Refractory Thyr...
Refractory Thyr...
Refractory Thyr...
Unresectable Th...
Cediranib
Cediranib Malea...
Laboratory Biom...
Lenalidomide
18 Years - National Cancer Institute (NCI)
Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid CancerNCT01208051
Refractory Diff...
Refractory Thyr...
Refractory Thyr...
Refractory Thyr...
Unresectable Th...
Cediranib
Cediranib Malea...
Laboratory Biom...
Lenalidomide
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: